Show simple item record

dc.contributor.authorBelhassen García, Moncef 
dc.contributor.authorAlonso Sardón, Montserrat 
dc.contributor.authorMartínez Pérez, Ángela
dc.contributor.authorSoler, Cristina
dc.contributor.authorCarranza Rodríguez, Cristina
dc.contributor.authorPérez-Arellano, José Luis
dc.contributor.authorMuro Alvarez, Antonio 
dc.contributor.authorSalvador, Fernando
dc.date.accessioned2020-01-27T16:35:44Z
dc.date.available2020-01-27T16:35:44Z
dc.date.issued2017-12-28
dc.identifier.citationBelhassen-García M, Alonso-Sardón M, Martinez-Perez A, Soler C, Carranza-Rodriguez C, Pérez-Arellano JL, et al. (2017) Surveillance of strongyloidiasis in Spanish in-patients (1998–2014). PLoS ONE 12(12):e0189449. https://doi.org/10.1371/journal.pone.0189449es_ES
dc.identifier.urihttp://hdl.handle.net/10366/140698
dc.description.abstract[EN]Background: Strongyloides stercoralis is a parasite that causes strongyloidiasis, a neglected tropical disease. S. stercoralis is a soil-transmitted helminth that is widely distributed in tropical and subtropical regions of the world. Strongyloidiasis can occur without any symptoms or as a chronic infection characterized by mild, unspecific symptoms such as pruritus, abdominal pain or discomfort; respiratory impairment also may manifest as a potentially fatal hyperinfection or disseminated infection. Most studies on strongyloidiasis in Spain have been related to chronic forms in immigrants or travellers from endemic zones and have mainly analysed out-patient populations. Studies of the impact of strongyloidiasis cases admitted to hospitals in Spain are lacking. Therefore, the aim of this study was to analyse the impact of strongyloidiasis in hospital care in Spain. Methodology: We designed a retrospective descriptive study using the Minimum Basic Data Set (MBDS, CMBD in Spanish) for inpatients with ICD-9: 127.2 (strongyloidiasis) diagnoses admitted to hospitals in the Spanish National Health System between 1998 and 2014. Principal findings: A total of 507 hospitalizations with diagnosis of strongyloidiasis were recorded, 324 cases (63.9%) were males. The mean (±SD) age was 42.1±20.1 years. The impact of strongyloidiasis on the total population of Spain was 0.06 cases per 105 person-years, and the infection burden increased progressively over time (from 0.01 cases per 105 person-years in 1999 to 0.10 cases per 105 person-years in 2014). 40 cases (7.9%) died. The total cost was approximately €8,681,062.3, and the mean cost per patient was €17,122.4±97,968.8. Conclusions: Our data suggest that strongyloidiasis is frequent in Spain and is increasing in incidence. Therefore, it would be desirable to improve the oversight and surveillance of this condition. Due to the fact that strongyloidiasis can be fatal, we believe that there is a need to establish risk categories for inclusion in national guidelines/protocols for screening individuals at risk of developing strongyloidiasis.es_ES
dc.language.isoenges_ES
dc.publisherPublic Library of Science.es_ES
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectStrongyloidiasises_ES
dc.subjectEstrongiloidiasises_ES
dc.subject.meshStrongyloidiasis *
dc.titleSurveillance of strongyloidiasis in Spanish in-patients (1998–2014)es_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.identifier.doihttps://doi.org/10.1371/journal.pone.0189449
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses_ES
dc.identifier.essn1932-6203
dc.journal.titlePLOS ONEes_ES
dc.volume.number12es_ES
dc.issue.number12es_ES
dc.type.hasVersioninfo:eu-repo/semantics/publishedVersiones_ES
dc.subject.decsestrongiloidiasis *


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivatives 4.0 Internacional